These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7586638)

  • 1. A search for three known RYR1 gene mutations in 41 Swedish families with predisposition to malignant hyperthermia.
    Fagerlund TH; Islander G; Twetman ER; Berg K
    Clin Genet; 1995 Jul; 48(1):12-6. PubMed ID: 7586638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Search for three known mutations in the RYR1 gene in 48 Danish families with malignant hyperthermia.
    Fagerlund T; Ording H; Bendixen D; Berg K
    Clin Genet; 1994 Dec; 46(6):401-4. PubMed ID: 7889656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia susceptibility, an autosomal dominant disorder?
    Fagerlund TH; Islander G; Ranklev Twetman E; Berg K
    Clin Genet; 1997 Jun; 51(6):365-9. PubMed ID: 9237497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes.
    Keating KE; Giblin L; Lynch PJ; Quane KA; Lehane M; Heffron JJ; McCarthy TV
    J Med Genet; 1997 Apr; 34(4):291-6. PubMed ID: 9138151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method to detect the RYR1 mutation G1021A, a cause of malignant hyperthermia susceptibility.
    Alestrøm A; Fagerlund TH; Berg K
    Clin Genet; 1995 May; 47(5):274-5. PubMed ID: 7554356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia.
    O'Brien RO; Taske NL; Hansbro PM; Matthaei KI; Hogan SP; Denborough MA; Foster PS
    J Med Genet; 1995 Nov; 32(11):913-4. PubMed ID: 8592342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibility.
    Fagerlund T; Ording H; Bendixen D; Islander G; Ranklev-Twetman E; Berg K
    Clin Genet; 1996 Apr; 49(4):186-8. PubMed ID: 8828983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies.
    Quane KA; Keating KE; Manning BM; Healy JM; Monsieurs K; Heffron JJ; Lehane M; Heytens L; Krivosic-Horber R; Adnet P
    Hum Mol Genet; 1994 Mar; 3(3):471-6. PubMed ID: 8012359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle.
    Richter M; Schleithoff L; Deufel T; Lehmann-Horn F; Herrmann-Frank A
    J Biol Chem; 1997 Feb; 272(8):5256-60. PubMed ID: 9030597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility.
    Moroni I; Gonano EF; Comi GP; Tegazzin V; Prelle A; Bordoni A; Bresolin N; Scarlato G
    J Neurol; 1995 Feb; 242(3):127-33. PubMed ID: 7751854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between the neuroleptic malignant syndrome and mutations in the RYR1 gene associated malignant hyperthermia.
    Miyatake R; Iwahashi K; Matsushita M; Nakamura K; Suwaki H
    J Neurol Sci; 1996 Nov; 143(1-2):161-5. PubMed ID: 8981316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.
    Quane KA; Keating KE; Healy JM; Manning BM; Krivosic-Horber R; Krivosic I; Monnier N; Lunardi J; McCarthy TV
    Genomics; 1994 Sep; 23(1):236-9. PubMed ID: 7829078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G1021A substitution in the RYR1 gene does not cosegregate with malignant hyperthermia susceptibility in a British pedigree.
    Adeokun AM; West SP; Ellis FR; Halsall PJ; Hopkins PM; Foroughmand AM; Iles DE; Robinson RL; Stewart AD; Curran JL
    Am J Hum Genet; 1997 Apr; 60(4):833-41. PubMed ID: 9106529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families.
    Iles DE; Lehmann-Horn F; Scherer SW; Tsui LC; Olde Weghuis D; Suijkerbuijk RF; Heytens L; Mikala G; Schwartz A; Ellis FR
    Hum Mol Genet; 1994 Jun; 3(6):969-75. PubMed ID: 7951247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees.
    Keating KE; Quane KA; Manning BM; Lehane M; Hartung E; Censier K; Urwyler A; Klausnitzer M; Muller CR; Heffron JJ
    Hum Mol Genet; 1994 Oct; 3(10):1855-8. PubMed ID: 7849712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia.
    Quane KA; Healy JM; Keating KE; Manning BM; Couch FJ; Palmucci LM; Doriguzzi C; Fagerlund TH; Berg K; Ording H
    Nat Genet; 1993 Sep; 5(1):51-5. PubMed ID: 8220423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hyperthermia--a large kindred linked to the RYR1 gene.
    Wallace AJ; Wooldridge W; Kingston HM; Harrison MJ; Ellis FR; Ford PM
    Anaesthesia; 1996 Jan; 51(1):16-23. PubMed ID: 8669559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia.
    Gillard EF; Otsu K; Fujii J; Duff C; de Leon S; Khanna VK; Britt BA; Worton RG; MacLennan DH
    Genomics; 1992 Aug; 13(4):1247-54. PubMed ID: 1354642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
    Muniz VP; Silva HC; Tsanaclis AM; Vainzof M
    J Mol Neurosci; 2003; 21(1):35-42. PubMed ID: 14500992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary].
    Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.